HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)
- 21 June 2017
- journal article
- review article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 48 (3) , 276-280
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- General Selection Criteria of Patients for Radioembolization of Liver TumorsAmerican Journal of Clinical Oncology, 2011
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2009
- Liver disease induced by radioembolization of liver tumorsCancer, 2008
- Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantationJournal of Surgical Oncology, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Success as Defined by Histologic Examination of the Explanted LiverRadiology, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- POSITRON EMISSION TOMOGRAPHY IMAGING IN ONCOLOGYRadiologic Clinics of North America, 2001
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996